PTC Therapeutics, Inc.: operating_income
| Value | {"amount": -374443000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | PTC Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:36:06.501058+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1fa7c9ee-c808-49ae-8445-2fd63c0982e4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001070081-22-000011Retrieved: 2026-08-19T10:36:06.501058+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001070081/operating-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1fa7c9ee-c808-49ae-8445-2fd63c0982e4
History
- no predecessors — first report